(Q37025782)

17 August 2017

1 reference

title

Adjuvant chemotherapy for adults with malignant glioma: a systematic review (English)

1 reference

17 August 2017

1 reference

1 reference

6

J Gregory Cairncross

1 reference

17 August 2017

James Perry

1

1 reference

17 August 2017

Normand Laperriere

2

1 reference

17 August 2017

Lisa Zuraw

3

1 reference

17 August 2017

Alexandra Chambers

4

1 reference

17 August 2017

Karen Spithoff

5

1 reference

17 August 2017

Neuro-oncology Disease Site Group

7

1 reference

17 August 2017

Cancer Care Ontario Program in Evidence-Based Care

8

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Canadian Journal of Neurological Sciences

17 August 2017

published in

1 reference

17 August 2017

volume

34

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

402-410

1 reference

Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Chemotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Chemosensitive gliomas in adults: which ones and why?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Adjuvant nitrosourea therapy for glioblastoma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Challenges in the design and conduct of phase III brain tumor therapy trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Controlled study of CCNU and radiation therapy in malignant astrocytoma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Effects of ACNU and radiotherapy on malignant glioma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter tr

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Glioblastoma multiforme. An analysis of the results of postoperative radiotherapy alone versus radiotherapy and concomitant 5-fluorouracil. (A prospective randomized study of 32 cases)

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Cisplatin does not enhance the effect of radiation therapy in malignant gliomas. EORTC Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100007265

7 January 2021

10.1017/S0317167100007265

Identifiers

DOI

0 references

1 reference